The purpose of this study is to investigate the 3-year outcomes of intravitreal brolucizumab and determine the factors that affect the visual acuity (VA) in patients with neovascular age-related macular degene…
You are here: Home / Three-year visual outcomes after brolucizumab in patients with neovascular age-related macular degeneration
Leave a Reply